Criterios de búsqueda

Gran Área: Ciencias médicas y de la salud
Área: Medicina clínica
Subárea: Neurología clínica

Búsqueda

 


Resultado: 169 registro(s)

8256

Cognitive Behavioral Treatment of Insomnia

A Session-by-Session Guide

 

13th ed. New York, NY: Springer Science+Business Media, 2005.

ISBNs 9780387222523 9780387291802

Colección: SpringerLink


Cobertura temática

Acceder

9586

Complex Medical Engineering

 

13th ed. Tokyo: Springer, 2007.

ISBNs 9784431309611 9784431309628

Colección: SpringerLink


Cobertura temática

Acceder

9489

Complicazioni neurologiche in oncologia, Le

 

13th ed. Milano: Springer-Verlag, 2006.

ISBNs 9788847004399 9788847004405

Colección: SpringerLink


Cobertura temática

Acceder

3525

Costi sociali e aspetti farmacoeconomici

Vol. 4

 

13th ed. Milano: Springer-Verlag, 2005.

Título de la serie/colección: Aspetti psico-sociali della sclerosi multipla.

ISBNs 9788847003279 9788847004016

Colección: SpringerLink


Cobertura temática

Acceder

17665

Developing Therapeutics for Alzheimer's Disease

Progress and Challenges

 

Academic Press, 2016.

ISBNs 9780128021736

Colección: ScienceDirect

Resumen (en inglés):

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer’s disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area.

Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer’s disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer’s disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics.

  • Provides a realistic but promising assessment of the potential of various therapeutic approaches to Alzheimer’s disease
  • Focuses primarily on neuroprotective agents and cognitive enhancers, as well as approaches to targeting the amyloid B-peptide, tau and Apolipoprotein E
  • Discusses alternative approaches, preclinical and clinical development issues, related biomarkers and diagnostics, and prevention and nonpharmacological approaches


Cobertura temática

Acceder

9713

Diabetic Neuropathy

Clinical Management

 

2nd ed. Totowa, NJ: Humana Press Inc., 2007.

Título de la serie/colección: Clinical Diabetes.

ISBNs 9781588296269 9781597453110

Colección: SpringerLink


Cobertura temática

Acceder

9754

Diagnostic Criteria in Neurology

 

13th ed. Totowa, NJ: Humana Press Inc., 2006.

Título de la serie/colección: Current Clinical Neurology.

ISBNs 9781588294821 9781597450782

Colección: SpringerLink


Cobertura temática

Acceder

2900

Dictionary of Neurological Signs, A

 

2nd ed. New York, NY: Springer Science+Business Media, 2006.

ISBNs 9780387262147 9780387312170

Colección: SpringerLink


Cobertura temática

Acceder

17773

Drug Design and Discovery in Alzheimer's Disease

 

Elsevier, 2015.

ISBNs 9780128039595

Colección: ScienceDirect

Resumen (en inglés):

Drug Design and Discovery in Alzheimer’s Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of β-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery.

  • Edited and written by leading experts in Alzheimer’s disease (AD) and other neurodegenerative disease drug development
  • Describes existing drugs for AD and current molecular understanding of the condition
  • Reviews recent advances in the field, including coverage of cholinesterases, BACE-1, and other drug development targets


Cobertura temática

Acceder

17838

EEG Pearls

 

Mosby, 2007.

ISBNs 9780323042338

Colección: ScienceDirect

Resumen (en inglés): This book uses the unique vignette format of the best-selling Pearls Series® to explore the basic principles of electroencephalography (EEG), as well as acquisition and interpretation of EEG findings. Real-life case studies—with physical findings, EEG readings, and clinical photos—show you how to recognize normal waking and sleep EEG readings as well as findings associated with the full range of epilepsy and seizure syndromes.


Cobertura temática

Acceder


Los iconos de las disciplinas fueron generados desde flaticon.com bajo licencia CC BY.